Rho-GTPase activating protein 18: a biomarker associated with good prognosis in invasive breast cancer

Rho-GTPase activating protein 18: a biomarker associated with good prognosis in invasive breast cancer

Background: The prognostic value of lymphovascular invasion (LVI) in breast cancer (BC) has been demonstrated in several independent studies. However, identification of driver molecules for LVI remains a challenging task. Large-scale transcriptomic profiling of histologically validated LVI can poten...

Full description

Bibliographic Details
Main Authors: Aleskandarany, Mohammed A., Sonbul, Sultan N., Surridge, Rachel, Mukherjee, Abhik, Caldas, Carlos, Diez-Rodriguez, Maria, Ashankyty, I., Albrahim, Khalil I., Elmouna, Ahmed M., Aneja, Ritu, Martin, Stewart G., Ellis, Ian O., Green, Andrew R., Rakha, Emad A.
Format: Article
Published: Cancer Research UK 2017
Subjects:
ARHGAP18
Lymphovascular invasion
Immunohistochemistry
Breast cancer
Prognosis
Online Access:https://eprints.nottingham.ac.uk/44298/

Internet

https://eprints.nottingham.ac.uk/44298/

Similar Items